Novel molecular profiles of endometrial cancer-new light through old windows.
about
Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometriumEndometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical DilemmasThe obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white womenF-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2.Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer riskPGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.Molecular profiling of endometrial malignancies.Genetics of endometrial cancersDifferential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth.Promising novel therapies for the treatment of endometrial cancerAlteration of the k-ras gene expression in atypical and nonatypical hyperplastic endometriumLaser capture microdissection with genome-wide expression profiling displayed gene expression signatures in endometrioid endometrial cancer.Molecular markers of endometrial carcinoma detected in uterine aspirates.Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.Factors associated with Type I and Type II endometrial cancer.Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.Microsatellite instability in endometrial polypsHuman endometrial cells express elevated levels of pluripotent factors and are more amenable to reprogramming into induced pluripotent stem cells.Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: a prospective cohort study.Endometrial Adenocarcinoma in A 31-Year Old Woman: A Case ReportInvolvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.MicroRNA heterogeneity in endometrial cancer cell lines revealed by deep sequencingUterine Carcinomas in Tetrabromobisphenol A-exposed Wistar Han Rats Harbor Increased Tp53 Mutations and Mimic High-grade Type I Endometrial Carcinomas in Women.Involvements of Estrogen Receptor, Proliferating Cell Nuclear Antigen and p53 in Endometrial Adenocarcinoma Development in Donryu Rats.The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study.Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma.Odds ratio analysis in women with endometrial cancer.Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancerDiagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine CorpusIndividualised proteome profiling of human endometrial tumours improves detection of new prognostic markers.FOXP1 forkhead transcription factor is associated with the pathogenesis of endometrial cancerPreoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.Loss of the cell polarity determinant human Discs-large is a novel molecular marker of nodal involvement and poor prognosis in endometrial cancerIntake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer.Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinomaSynuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
P2860
Q27012789-4ED31486-4F2F-48C3-80C5-13F24B3F67D9Q28074769-88C931BE-651F-4274-8119-88AAC99836A7Q28742979-854F85EE-52D9-4CB5-AB8C-16FFFD6A5DE6Q33525705-6AEFD933-DD60-4ED6-A98A-51DEE94753BDQ33633962-4367DBED-A2ED-44EF-BF6D-0E69F5D7F3FCQ33636878-45EE2800-7348-4F1F-ABC7-DFFB1EC7C518Q33692377-62E7FEAD-EB03-4DC8-8972-FFFBE3383AD0Q33757898-DF4DBA33-44B4-40DE-A8D1-27622F0B2DAEQ33781274-8B5C2C0B-6843-44A9-BB59-03830626EE90Q33882527-CAED07AD-3926-4223-9705-3E6D09BBE139Q33903900-F97CABD0-AFB0-4203-ADB9-E7AF3DFE3D7EQ33920661-D2DA4BD7-0543-4397-89CF-FBA1731A6D9EQ34082455-011FD277-4FA2-48BB-B689-39165B63747EQ34084754-2020D4A2-A593-4998-98C5-D04A2E85A367Q34157607-3C17B6BD-EF9C-4B56-ABEE-BBF0091C2B23Q34231069-15E70B9C-592B-495F-893F-327B28929CB2Q34233057-A221A365-80F6-41C4-8171-794D1A85A94EQ34291001-F1CAB7B4-5DB9-433B-B92F-836C208F1778Q34562166-32E87E29-CDEA-4031-B817-D3FB358D2881Q35248811-E99A8F2F-5461-4776-AD2A-1BA1C6F659D4Q35416543-37603F45-3533-4FAA-8B01-297547A5EFFEQ35450748-97B5B258-706E-4DA7-870A-4A6752A5875EQ35898976-078247BA-7DBD-4091-ABF1-926D96870403Q36231752-C7656F76-AAFD-49E9-BA92-92AEF53BB4C6Q36334541-C35BD031-6E97-434B-95EB-9F0E3CCB4712Q36348291-4E121E00-1D7C-44E0-964C-5F6C3570314BQ36455125-316AAB2B-623F-4804-A311-99EFA903BF0DQ36651350-E7BE8819-DFB4-43F9-A4CE-A79E3CD1BE17Q36661765-BEE5E1A3-05FD-46D8-96F7-01DDE25F3128Q36706870-20AEC0E3-B399-47FD-A528-399FF8B4F673Q36789357-E1FC72A5-0317-4811-8A9D-8332836AFC27Q37007297-D858338B-BF8E-4BD9-9D55-CA5BDE298827Q37011743-C031114F-A072-47A8-B9AB-520159FA1814Q37081947-98DFDE21-C3F5-4298-A7D3-DB440E299E7BQ37097153-9856B632-3D51-4487-BEA1-0CCCBE42A14BQ37136039-3B4E372F-DCAE-46F6-A896-EE69E4BD030CQ37175037-99C31B20-4532-4A93-8F1A-C0EEDBCC28C0Q37214356-C7A0DED0-54DA-4A65-8FC4-3A6937659998Q37266333-005103DA-FC40-4B06-A63A-299314705E6FQ37305478-41F4A135-2BF2-4C59-BBDC-A5CC341A83B9
P2860
Novel molecular profiles of endometrial cancer-new light through old windows.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel molecular profiles of endometrial cancer-new light through old windows.
@en
Novel molecular profiles of endometrial cancer-new light through old windows.
@nl
type
label
Novel molecular profiles of endometrial cancer-new light through old windows.
@en
Novel molecular profiles of endometrial cancer-new light through old windows.
@nl
prefLabel
Novel molecular profiles of endometrial cancer-new light through old windows.
@en
Novel molecular profiles of endometrial cancer-new light through old windows.
@nl
P2093
P50
P1476
Novel molecular profiles of endometrial cancer-new light through old windows
@en
P2093
H Alazzouzi
J Planagumá
J Reventós
M A Lohmann
M Gonzalez
M Llauradó
P304
P356
10.1016/J.JSBMB.2007.09.020
P577
2007-09-15T00:00:00Z